Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Friendly Hemp is a wellness-focused company that specializes in the development and retail of hemp-derived cannabinoid products. The company's product portfolio includes a range of CBD, Delta-8, and Delta-9 THC offerings, primarily delivered through edibles like gummies, as well as tinctures and topical applications. Their business model focuses on providing accessible cannabinoid solutions for common health concerns such as sleep quality, stress reduction, and minor pain relief. Friendly Hemp utilizes third-party laboratory testing to verify the purity and potency of its products, catering to the growing consumer market for legal hemp derivatives. The company emphasizes transparency and quality in its manufacturing processes to ensure consumer safety.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Friendly Hemp.